A promising treatment for cancer using a patient’s own cells could begin clinic trials in Western Australia by the end of the year under a state government-backed initiative.
Perth-registered Singaporean regenerative medtech company Osteopore has struck an exclusive distribution agreement with global medtech leader Zimmer Biomet.
Western Australia will establish Australia’s first dedicated RNA development centre for cancer treatments after $2 million was invested by the state government.
A tender to redevelop medical facilities in Paraburdoo and Tom Price is expected to be released next month, with the projects set to be delivered under a state government initiative.
Researchers from UWA and the Perron Institute have discovered a new set of cells which can protect blood vessel structure in the central nervous system, know as the blood-brain barrier.
Nedlands-based health tech innovator Proteomics International Laboratories has appointed Eurobio Scientific to distribute its PromarkerD test in France.
Leederville-based medical dermatology company Botanix has announced it will tap investors for $70 million to fund the launch of its recently US Food and Drug Administration approved Sofdra gel.
Leederville-based medical dermatology company Botanix has received US Food and Drug Administration approval for its Sofdra gel, used to treat excessive underarms sweating.
The Australian Competition and Consumer Protection has voiced concerns over Sigma’s proposed acquisition of Chemist Warehouse, including potential barriers for other pharmacy retailers to expand.
Shares in Perth biotech company PharmAust rose by 14 per cent on Friday to 21 cents, following news Michael Thurn had been reappointed as the company’s managing director and chief executive officer.
Avita Medical shares have had a moderate rise after a US regulator approved the next reiteration of a regenerative cell system for burns developed by Perth surgeon Fiona Wood.
Michael Anghie-led APM Human Services International has entered a trading halt, pending an update regarding its non-binding acquisition proposal from US-based Madison Dearborn Partners.
Home care provider Silverchain has launched a philanthropic foundation to invest in new models of care, improve technology and increase access to health and aged care services.
Perth biotech company PYC Therapeutics has hit a major milestone in the development of a first-in-class drug to treat a rare eye disease, recently receiving orphan drug designation from the US FDA.
A health facility housing an MRI, medical imaging, GP and daycare backed by Broome dental clinic owner Stephanie Mulcahy has been earmarked for the Kimberley town.
